Prognostic Significance of CpG Island Methylator Phenotype in Colorectal Cancer

참고문헌 (10)

1. Brenner H, "Colorectal cancer", Lancet, 383, pp.1490~1502 (2014)
2. Riethdorf S, "Review: biological relevance of disseminated tumor cells in cancer patients", Int J Cancer, 123, pp.1991~2006 (2008)
3. 김은란, "Clinical Application of Genetics in Management of Colorectal Cancer", Intestinal research, 12(3), pp.184~193 (2014), 대한장연구학회
4. Zoratto F, "Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis", Tumour Biol, 35, pp.6195~6206 (2014)
5. Juo YY, "Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis", Ann Oncol, 25, pp.2314~2327 (2014)
6. Sideris M, "Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer", Anticancer Res, 34, pp.2061~2068 (2014)
7. Shiovitz S, "CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer", Gastroenterology, 147, pp.637~645 (2014)
8. 강기주, "The Role of the CpG Island Methylator Phenotype on Survival Outcome in Colon Cancer", Gut and Liver, 9(2), pp.202~207 (2015), 거트앤리버 발행위원회
9. Kim JH, "Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers", Virchows Arch, 455, pp.485~494 (2009)
10. Bae JM, "Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location", Br J Cancer, 109, pp.1004~1012 (2013)